Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention

NCT02273700 ·Status: COMPLETED

RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke

NCT02129920 ·Status: UNKNOWN

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

NCT03746301 ·Status: COMPLETED

Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

NCT03749057 ·Status: COMPLETED ·Phase: PHASE4

Real-Life Evidence on Stroke Prevention in SPAF

NCT02485873 ·Status: COMPLETED

Rivaroxaban Evaluation in Real Life Settings

NCT02444221 ·Status: COMPLETED

Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation

NCT02042534 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation

NCT05262322 ·Status: COMPLETED

Intravenous Thrombolysis and NOAC

NCT06749834 ·Status: RECRUITING ·Phase: PHASE3

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

NCT03772457 ·Status: UNKNOWN

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

NCT03062319 ·Status: TERMINATED ·Phase: PHASE4

The Bleeding With Antithrombotic Therapy Study 2

NCT02889653 ·Status: COMPLETED

Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF

NCT06057467 ·Status: RECRUITING ·Phase: NA

Rivaroxaban Acute Stroke Safety Study

NCT02279940 ·Status: COMPLETED

Xarelto [SPAF] Post-marketing Surveillance in Japan

NCT01582737 ·Status: COMPLETED

Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis

NCT06058130 ·Status: RECRUITING ·Phase: NA

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

NCT02640222 ·Status: COMPLETED

Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial

NCT02818868 ·Status: COMPLETED

SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)

NCT01581502 ·Status: UNKNOWN

Biomarkers of Acute Stroke in Clinic

NCT03897478 ·Status: UNKNOWN

The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation

NCT06864052 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

NCT05445895 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Evolocumab in Ischemic Stroke

NCT05697185 ·Status: UNKNOWN ·Phase: PHASE4

Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema

NCT05399550 ·Status: WITHDRAWN ·Phase: PHASE2

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

NCT01983358 ·Status: COMPLETED ·Phase: PHASE1